Table 4.
Comparison of clinical and laboratory data of patients receiving or not receiving albumin infusions or thromboembolic prophylaxisa
| Clinical and laboratory data | ||||||
|---|---|---|---|---|---|---|
| Albumin infusion | Albumin (g/dL) | Serum Na (mmol/L) | Urine output (mL/kg/h) | sBP (SDS) | dBP (SDS) | BMI (SDS) |
| Yes | 1.46 ± 0.4 | 135.3 ± 3.4 | 1.6 ± 1.1 | 1.2 ± 1.1 | 1.4 ± 1.0 | 0.9 ± 1.0 |
| No | 1.36 ± 0.4 | 137.1 ± 2.8 | 1.1 ± 0.8 | 0.9 ± 1.13 | 1.05 ± 0.8 | 0.6 ± 1.0 |
| p value | NS | NS | NS | NS | NS | NS |
| Thromboembolic prophylaxis (ASA) | Albumin (g/dL) | Platelets (×103/μL) | Antithrombin III (%) | Fibrinogen (mg/dL) | Cholesterol (mg/dL) | Triglycerides (mg/dL) |
| Yes | 1.3 ± 0.4 | 438 ± 18.0 | 65 ± 4.0 | 687 ± 34 | 397 ± 12.2 | 196 ± 15.0 |
| No | 1.4 ± 0.4 | 430 ± 10.9 | 71 ± 4.1 | 651 ± 25 | 402 ± 8.5 | 217 ± 12.7 |
| p value | NS | NS | NS | NS | NS | NS |
sBP, Systolic blood pressure; dBP, diastolic blood pressure; NS, not significant
aThis analysis did not reveal any difference between the two group in terms of Albumin infusion and thromboembolic prophylaxis. No differences were found when data were analyzed separately in children treated by pediatricians and pediatric nephrologists